Anti-CD20 Monoclonal Antibodies (mABs) Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2028

  • Single User License $3500

Anti-CD20 Monoclonal Antibodies (mABs) Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2028

Status : March, 2020 | Pharmaceutical | PPT format

Report Digest


Global Anti-CD20 Monoclonal Antibodies (mABs) Market: Overview 

There are various drugs available in the market for the treatment of diseases like cancer, autoimmune disorders, and various other neurological disorders. However, majority of these drugs have side-effects associated with them which are resulting low patient adherence. Owing to these side-effects and various research and developments in the field of targeted therapies, like anti-CD20 mABs, have increased over the period of time. As a result of these R&D, these new drugs have significantly low side-effects. This is the prime reason that is fueling the growth of global anti-CD20 monoclonal antibodies market during the forecast of 2018 to 2028. 

A report by TMR Research provides valuable insights on global anti-CD20 monoclonal antibodies market for the readers. The insights can help the readers to understand the dynamics of market which can be beneficial for them to have a sustainable future in global anti-CD20 monoclonal antibodies market. 

Global Anti-CD20 Monoclonal Antibodies (mABs) Market: Notable Developments 

Since the market is quite niche, various players are heavily applying for the approval to Food and Drugs Administration or FDA. These approvals are mandatory for the players to use their drugs commercially. Also these players are also investing in research and development departments to develop drugs that have less side-effects on the patients. These strategies by the players are their resort to withstand the competition of global anti-CD20 monoclonal antibodies market. 

Some of the instances of players adopting strategies for a successful future in market are mentioned below: 

  • In June 2019, Roche Holding AG gained the FDA approval for its polatuzumab vedotin-piiq drug Poilvy. The drug is aimed to treat lymphoma and has 25% less side effects than those from traditional drugs that are available in the market. AS a result of this approval the company can commercialize its drug and acquire major share of global anti-CD20 monoclonal antibodies market. 
  • In August 2019, Amgen acquired Otezla and gained the access to the company’s technology to enhance its portfolio of anti-CD20 monoclonal antibodies drugs. As a result of this acquisition, the company acquired a 35% shares responsible for the growth of global anti-CD20 monoclonal antibodies market. 

Some of the players of global anti-CD20 monoclonal antibodies market are mentioned below:

  • Pfizer Inc
  • Hoffmann-La Roche Ltd.
  • Celltrion Inc.
  • Novartis AG
  • Amgen Inc. 

Global Anti-CD20 Monoclonal Antibodies Market: Key Drivers

Precision targeting of anti-CD20 mABs 

Anti-CD20 mABs are extensively effective as target therapies in treating cancer indications. These drugs target CD20 antigen on the cancer cells which is not possible in traditional therapies. Increasing research and developments in this field and various affirmative clinical trials are expected to boost the growth of global anti-CD20 monoclonal antibodies (mABs) market. 

Technological Developments in Healthcare Sectors 

Players in global anti-CD20 monoclonal antibodies (mABs) market are acquiring major share of the market based on the technological developments in various healthcare sectors. For instance, developments in pharmaceutical sector in improving the efficacy of the drugs and development of bispecific antibodies are some of the major factors that are influencing the growth of global anti-CD20 monoclonal antibodies (mABs) market in the forecast period of 2018 to 2028. 

Global Anti-CD20 Monoclonal Antibodies (Mabs) Market: Regional Analysis 

North America is expected to resister the maximum potential for the players of global anti-CD20 monoclonal antibodies market. The dominance of the region is expected to be the result of rising provenances of hematological malignancies such as NHL and recent approval of various late-stage pipeline drugs in countries like U.S. Moreover, the presence of various prominent players of global anti-CD20 monoclonal antibodies market in the region is further expected to boost the growth of North America in the anti-CD20 monoclonal antibodies market. 

The global anti-CD20 monoclonal antibodies market is segmented on the basis of:

  • Product 
    • Oncology
    • Neurology
    • Immunology

The study presents a granular assessment and quantitative evaluation of:

  • Key growth factors and prominent trends
  • Size and share of key segments in overall market
  • Key challenges and winning imperatives
  • Factors shaping competitive landscape
  • Insights into how contours of market will change in coming years
  • Technological advances
  • New avenues and imminent investment pockets
  • Regulatory landscape shaping current and future strategies of companies

The region-wise assessment includes market dynamics in:

  • North America
  • Asia Pacific
  • Europe
  • Latin America
  • The Middle East and Africa

The study is prepared with the help of an extensive primary and secondary research. Primary research includes but not limited to interactions, interviews, surveys, and events. Opinions of policy makers and industry experts are carefully integrated into the insights to complement primary research. Volumes of secondary data gleaned through renowned paid sources, annual statements, reputed journals, and government documents offer insights into current dynamics and key evolution trajectories the market is likely to assume. The research employs various industry-wide analytics methods and well-established methodologies to ascertain the attractiveness of key segments. Further, it evaluates the lucrativeness of key regions and factors underlying their maturity. The insights notably include a detailed analysis of forces behind vendor differentiation and offers insight into investment-decision making by prominent players.

The report strives to enlighten businesses and industry stakeholders on multiple facets of the growth dynamic of the market, the key of which include answers to:

  • Which key factors will shape the competitive landscape?
  • Which trends will stimulate research and development activities in different geographies?
  • Which are the lucrative growth areas and what is the size of potential they are likely contribute to the overall market?
  • Which disruptions in market growth are likely to come with the new business models?
  • Which are some of the recent overhauls in policies that may change the course of the market significantly?
  • Which are the geographies that will form sizable sources of new streams to new and established players alike?
  • How are top players likely to realign their strategy to counter the forces of competition?
  • Which key strategies emerging players are likely to focus on to consolidate their position?
  • Which changes in end-user preferences might affect the status quo held by the leading players?
  • Which are some of the game-changing innovations influencing the projected share and revenue of the market and its segments?

Note: Utmost care has invariably been taken to present data and arrive at statistics at all the TMR Research reports. Meanwhile, some recent developments and new industry trends may take time to be included in the reports.

Wish to check Table of Contents of this report?

Click below to Request TOC

Request TOC